https://neurotrials.ai/journal/epilepsy/the-epilepsy-renaissance-new-mechanisms-new-molecules-and-the-dawn-of-genetic-therapy/2026-05-23T14:51:11+00:00https://neurotrials.ai/journal/neuromuscular/six-biologics-one-disease-zero-head-to-head-trials-how-do-you-actually-choose-in-myasthenia-gravis/2026-05-17T13:49:29+00:00https://neurotrials.ai/journal/dementia/the-new-era-of-alzheimer-disease-therapy-a-2026-neurologists-guide/2026-05-12T22:16:16+00:00https://neurotrials.ai/journal/headache/medication-overuse-headache-in-2026-withdraw-bridge-or-skip-straight-to-anti-cgrp/2026-05-09T22:25:25+00:00https://neurotrials.ai/journal/stroke/the-distal-dilemma-why-four-trials-failed-and-what-oriental-mevo-got-right/2026-05-06T01:48:47+00:00https://neurotrials.ai/journal/stroke/the-24-hour-thrombolysis-window-a-new-standard-for-acute-ischemic-stroke/2026-05-02T23:51:42+00:00https://neurotrials.ai/journal/stroke/glp-1-receptor-agonists-for-diabetic-stroke-prevention-reframing-clinical-value/2026-04-24T11:50:08+00:00https://neurotrials.ai/journal/stroke/glp-1-receptor-agonists-and-stroke-the-evidence-is-compelling-but-is-it-actually-about-stroke/2026-04-23T21:56:57+00:00https://neurotrials.ai/journal/stroke/closing-the-appendage-in-2026-from-rescue-device-to-default-option/2026-04-21T11:51:20+00:00https://neurotrials.ai/journal/stroke/pharyngeal-electrical-stimulation-for-post-stroke-dysphagia-a-fair-reckoning/2026-04-14T08:03:48+00:00https://neurotrials.ai/journal/stroke/the-ever-expanding-thrombolysis-window-from-4-5-hours-to-24-are-we-there-yet-1/2026-04-13T17:05:54+00:00https://neurotrials.ai/journal/stroke/factor-xia-inhibitors-the-third-revolution-in-stroke-antithrombotics/2026-04-13T17:05:37+00:00https://neurotrials.ai/journal/stroke/the-ldl-target-keeps-falling-from-100-to-70-to-55-are-we-there-yet/2026-04-12T00:34:55+00:00